Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Spring Kong

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Center|September 16, 2024
Precision radiation therapy in the modern era of multidisciplinary care in oncology: What matters to our patients and beyond?Feng-Ming Spring Kong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2018
What Happens When Proton Meets Randomization: Is There a Future for Proton Therapy?Feng-Ming Spring Kong
Seminars in Radiation Oncology|March 16, 2015
Nondosimetric risk factors for radiation-induced lung toxicityFeng-Ming Spring Kong, Shulian Wang
Translational Lung Cancer Research|September 18, 2015
Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?Rameses Sroufe, Feng-Ming Spring Kong
Advances in Experimental Medicine and Biology|December 26, 2015
Personalized Radiation Therapy (PRT) for Lung CancerJian-Yue Jin, Feng-Ming Spring Kong
Translational Lung Cancer Research|May 18, 2016
Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancerBryan M Rabatic, Feng-Ming Spring Kong
Translational Lung Cancer Research|May 18, 2016
Rebuttal from Prof. Kong and Dr. RabaticBryan M Rabatic, Feng-Ming Spring Kong
Annals of Translational Medicine|November 12, 2020
Why aren't we getting consistent results for heart dose and mortality during thoracic radiotherapy?Jianxin Xue, You Lu, Feng-Ming Spring Kong
Lung Cancer (Amsterdam, Netherlands)|October 18, 2011
Implementation of hypoxia measurement into lung cancer therapyXue Meng, Feng-Ming Spring Kong, Jinming Yu
Translational Lung Cancer Research|February 22, 2019
Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapyMichael T Milano, Feng-Ming Spring Kong, Benjamin Movsas
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Center|September 16, 2024
Precision radiation therapy in the modern era of multidisciplinary care in oncology: What matters to our patients and beyond?Feng-Ming Spring Kong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2018
What Happens When Proton Meets Randomization: Is There a Future for Proton Therapy?Feng-Ming Spring Kong
Seminars in Radiation Oncology|March 16, 2015
Nondosimetric risk factors for radiation-induced lung toxicityFeng-Ming Spring Kong, Shulian Wang
Translational Lung Cancer Research|September 18, 2015
Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?Rameses Sroufe, Feng-Ming Spring Kong
Advances in Experimental Medicine and Biology|December 26, 2015
Personalized Radiation Therapy (PRT) for Lung CancerJian-Yue Jin, Feng-Ming Spring Kong
Translational Lung Cancer Research|May 18, 2016
Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancerBryan M Rabatic, Feng-Ming Spring Kong
Translational Lung Cancer Research|May 18, 2016
Rebuttal from Prof. Kong and Dr. RabaticBryan M Rabatic, Feng-Ming Spring Kong
Annals of Translational Medicine|November 12, 2020
Why aren't we getting consistent results for heart dose and mortality during thoracic radiotherapy?Jianxin Xue, You Lu, Feng-Ming Spring Kong
Lung Cancer (Amsterdam, Netherlands)|October 18, 2011
Implementation of hypoxia measurement into lung cancer therapyXue Meng, Feng-Ming Spring Kong, Jinming Yu
Translational Lung Cancer Research|February 22, 2019
Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapyMichael T Milano, Feng-Ming Spring Kong, Benjamin Movsas
Pageof 17